Gene · 4486
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MAGOH promotes gastric cancer progression via hnRNPA1 expression inhibition-mediated RONΔ160/PI3K/AKT signaling pathway activation. | J Exp Clin Cancer Res | 2024 | 38268030 | PubTator, text mining | PubMed |
| The Need for Novel Asexual Blood-Stage Malaria Vaccine Candidates for Plasmodium falciparum. | Biomolecules | 2024 | 38254700 | PubTator, text mining | PubMed |
| Macrophage stimulating protein is a novel transcriptional target of estrogen related receptor gamma in alcohol-intoxicated mice. | Cell Signal | 2024 | 38237793 | PubTator, text mining | PubMed |
| Inhibition of autocrine HGF maturation overcomes cetuximab resistance in colorectal cancer. | Cell Mol Life Sci | 2024 | 38212428 | PubTator, text mining | PubMed |
| Non-coding RNAs as potential therapeutic targets for receptor tyrosine kinase signaling in solid tumors: current status and future directions. | Cancer Cell Int | 2024 | 38200584 | PubTator, text mining | PubMed |
| Mechanism of ferroptosis in breast cancer and research progress of natural compounds regulating ferroptosis. | J Cell Mol Med | 2024 | 38140764 | PubTator, text mining | PubMed |
| The nexus of long noncoding RNAs, splicing factors, alternative splicing and their modulations. | RNA Biol | 2024 | 38017665 | PubTator, text mining | PubMed |
| The effect of adjunctive LASER application on periodontal ligament stem cells. | Front Cell Dev Biol | 2023 | 38283989 | PubTator, text mining | PubMed |
| Deciphering treatment resistance in metastatic colorectal cancer: roles of drug transports, EGFR mutations, and HGF/c-MET signaling. | Front Pharmacol | 2023 | 38269272 | PubTator, text mining | PubMed |
| Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatment. | Front Chem | 2023 | 38264122 | PubTator, text mining | PubMed |
| Mechanism of Antitumor Effects of Saffron in Human Prostate Cancer Cells. | Nutrients | 2023 | 38201944 | PubTator, text mining | PubMed |
| Benchmarking splice variant prediction algorithms using massively parallel splicing assays. | Genome Biol | 2023 | 38129864 | PubTator, text mining | PubMed |
| Genetic and observational associations of lung function with gastrointestinal tract diseases: pleiotropic and mendelian randomization analysis. | Respir Res | 2023 | 38102678 | PubTator, text mining | PubMed |
| Receptor tyrosine kinases: biological functions and anticancer targeted therapy. | MedComm (2020) | 2023 | 38077251 | PubTator, text mining | PubMed |
| Integrated investigation and experimental validation of PPARG as an oncogenic driver: implications for prognostic assessment and therapeutic targeting in hepatocellular carcinoma. | Front Pharmacol | 2023 | 38044948 | PubTator, text mining | PubMed |
| Predictive and prognostic biomarkers of bone metastasis in breast cancer: current status and future directions. | Cell Biosci | 2023 | 38041134 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| Human transcriptional signature of protection after Plasmodium falciparum immunization and infectious challenge via mosquito bites. | Hum Vaccin Immunother | 2023 | 38010150 | PubTator, text mining | PubMed |
| Regulation of Epithelial-Mesenchymal Transitions by Alternative Splicing: Potential New Area for Cancer Therapeutics. | Genes (Basel) | 2023 | 38002944 | PubTator, text mining | PubMed |
| Molecular and functional profiling of chemotolerant cells unveils nucleoside metabolism-dependent vulnerabilities in medulloblastoma. | Acta Neuropathol Commun | 2023 | 37978570 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4486/papers?page=4